Mesoridazine
Phenothiazine — NERVOUS SYSTEM
Also known as: mesoridazine besilate, mesoridazine besylate, thioridazine-2-sulfoxide
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Mesoridazine is an ofm drug in the Phenothiazine class catalogued in DrugCentral. It was first approved by the FDA in 1970. DrugCentral lists 15 molecular targets, including HRH1, DRD3 and HTR2A. Recorded indications include Schizophrenia.
- Approval status: ofm (first approved 1970 by the FDA).
- Drug class: Phenothiazine.
- Molecular targets: HRH1, DRD3, HTR2A and DRD4 (15 listed in DrugCentral).
- Indications: Schizophrenia.
- ATC code: N05AC03 (Phenothiazines with piperidine structure).
- Molecular formula: C21H26N2OS2; molecular weight 386.57 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Schizophrenia
Contraindications (13)
- Coma
- Conduction disorder of the heart
- Congenital long QT syndrome
- Epilepsy
- Granulocytopenic disorder
- Hyperkalemia
- Hypokalemia
- Neuroleptic malignant syndrome
- Orthostatic hypotension
- Predisposed to Torsades de Pointes Cardiac Arrhythmias
- Prolonged QT interval
- Stupor
- Tardive dyskinesia
Mechanism & targets
| Established pharmacologic class | Phenothiazine |
|---|
Molecular targets (15)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Histamine H1 receptor | HRH1 | unknown | Ki 8.74 |
| D(3) dopamine receptor | DRD3 | unknown | Ki 8.59 |
| 5-hydroxytryptamine receptor 2A | HTR2A | antagonist | Ki 8.12 |
| D(4) dopamine receptor | DRD4 | unknown | Ki 8.04 |
| Muscarinic acetylcholine receptor M1 | CHRM1 | unknown | Ki 8.00 |
| Muscarinic acetylcholine receptor M2 | CHRM2 | unknown | Ki 7.82 |
| D(2) dopamine receptor | DRD2 | antagonist | Ki 7.72 |
| Muscarinic acetylcholine receptor M4 | CHRM4 | unknown | Ki 7.72 |
| Muscarinic acetylcholine receptor M5 | CHRM5 | unknown | Ki 7.22 |
| Muscarinic acetylcholine receptor M3 | CHRM3 | unknown | Ki 7.05 |
| D(1A) dopamine receptor | DRD1 | antagonist | Ki 6.99 |
| 5-hydroxytryptamine receptor 1A | HTR1A | antagonist | Ki 6.98 |
| 5-hydroxytryptamine receptor 2C | HTR2C | unknown | Ki 6.80 |
| Potassium voltage-gated channel subfamily H member 2 | KCNH2 | unknown | IC50 6.50 |
| 5-hydroxytryptamine receptor 6 | HTR6 | unknown | Ki 6.42 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1970-02-27 | FDA | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
N05AC03 | NERVOUS SYSTEM › PSYCHOLEPTICS › ANTIPSYCHOTICS › Phenothiazines with piperidine structure |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Mesoridazine is on its molecule page.
| Molecular formula | C21H26N2OS2 |
|---|---|
| Molecular weight | 386.57 g/mol |
| CAS number | 5588-33-0 |
| InChIKey | SLVMESMUVMCQIY-UHFFFAOYSA-N |
| PubChem CID | 4078 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Mesoridazine used for?
DrugCentral lists the following indications for Mesoridazine: Schizophrenia.
How does Mesoridazine work?
Its molecular targets in DrugCentral include HRH1, DRD3, HTR2A (antagonist) and DRD4.
When was Mesoridazine first approved?
Mesoridazine was first approved by the FDA in 1970.
What drug class does Mesoridazine belong to?
Mesoridazine is in the Phenothiazine class.
What is the chemical formula of Mesoridazine?
Mesoridazine has the molecular formula C21H26N2OS2 and a molecular weight of 386.57 g/mol.
Browse: all drugs starting with M · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1712 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1088 — compound record and bioactivity
- PubChem CID 4078 — chemical identifiers
- DrugBank DB00933 — drug record
- FDA UNII 5XE4NWM740 — substance identity
- DailyMed: FDA labels for Mesoridazine — current prescribing information (label search)
- UniProt P35367 (HRH1) — target protein
- UniProt P35462 (DRD3) — target protein
- UniProt P28223 (HTR2A) — target protein
- UniProt P21917 (DRD4) — target protein
- UniProt P11229 (CHRM1) — target protein
- UniProt P08172 (CHRM2) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.